Author: Roboticulized.com

ddn-and-helmholtz-munich-host-2023-life-sciences-field-day-to-share-research-insights-and-best-practices

DDN and Helmholtz Munich Host 2023 Life Sciences Field Day to Share Research Insights and Best Practices

April 13, 2023 Published by

 

DDN®, the global leader in artificial intelligence (AI) and multi-cloud data management solutions, today announced its 2023 Life Sciences Field Day, hosted by Helmholtz Munich on May 4, 2023 at the Helmholtz Munich campus.

Life sciences research continues to grow rapidly in scientific importance and impact on society. New discovery methods based on AI are finding applications in basic scientific research and in clinical environments. In addition, cross-fertilization across different sub-disciplines promises to accelerate time to discovery in strategic research projects.

The 2023 Life Sciences Field Day is a unique opportunity for innovators, researchers, and industry leaders. The event will bring together experts from academia, pharmaceuticals, biotechnology, and research institutions to discuss the latest trends, challenges, and solutions in life sciences data management, storage, and analysis.

“We are thrilled to bring together leading minds in life sciences research to gather and share knowledge, experiences, and best practices at the 2023 Life Sciences Field Day,” said Tommaso Cecchi, senior director of Sales EMEA, DDN. “With speakers from a range of industries including agriculture, human genetics, and AI computing, attendees will have the opportunity to learn how these researchers and organizations have been successful and leverage that insight to advance their own data-driven discoveries.”

Attendees will hear from keynote speakers such as Dr. Fabian Theis,  Director of the Institute for Computational Biology at Helmholtz Munich & Technical University of Munich and winner of the Leibniz Prize 2023, the most prestigious research award in Germany. In addition, attendees will hear from panelists, engage in live discussions and tour the Helmholtz Munich Campus.

“Helmholtz Munich is dedicated to developing solutions for a healthier future, and our cutting-edge research is the springboard for medical innovation,” said Dr. Alf Wachsmann, head of DigIT Infrastructure & Scientific Computing, Helmholtz Munich. “We are honored to host the 2023 Life Sciences Field Day with the purpose of accelerating the transfer from ideas to applications with experts from across the life sciences community.”

Registration for the 2023 Life Sciences Field Day on May 4 is now open. For more information and to register, please visit https://www.ddn.com/company/events/2023-life-sciences-field-day/.

cybeats-addresses-recent-‘3cx’-cyberattack-and-highlights-government-agencies’-support-for-sboms

Cybeats Addresses Recent ‘3CX’ Cyberattack and Highlights Government Agencies’ Support for SBOMs

April 13, 2023 Published by

 

Cybeats Technologies Corp. (“Cybeats” or the “Company”) (CSE: CYBT) (OTCQB: CYBCF) highlights the challenges faced by nations in securing their infrastructure, particularly in the context of increasing software supply chain threats. The recent 3CX cyberattack carried out by North Korea nation state-backed hackers has public and private stakeholders calling for increased supply chain transparency.

In line with the tone set by the Cyber Executive Order (EO) 14028 from 20211, government agencies around the world are recognizing Software Bills of Materials (SBOM) as a required baseline to ensure security in software acquisition, market access and risk management processes. The recently released U.S. National Cyber Strategy (NCS) builds on SBOM efforts in the Cyber EO calling on U.S. Congress to change market incentives and establish liability for software products and services, and expand SBOM requirements. Cybeats is currently engaged with multiple government agencies responsible for safeguarding national security.

“Government agencies play an important role in ensuring that industry adopts standards of care for secure software development and maintenance of products and services, or face liability risks. As SBOM requirements become increasingly relevant to the government software procurement process, the private sector is rapidly embracing them as well. With the growing significance of SBOMs, organizations spanning diverse industries, such as finance, technology, industrial, medical, and automotive, are actively evaluating their Software Development Life Cycle and SBOM practices to meet the rising demand for SBOMs,” said Yoav Raiter, CEO of Cybeats.

3CX Software Supply Chain Attack

3CX has over 600,000 customers in 190 countries, representing over 12M users. Security firms have indicated that the 3CX hackers targeted both Windows and macOS users of the compromised 3CX softphone app. The malicious activity includes beaconing to actor-controlled infrastructure, deployment of second-stage payloads, and, in a small number of cases, hands-on-keyboard activity. Initial research indicates the number of potential victims is in the hundreds of thousands.

Cyberattacks like 3CX and SolarWinds have prompted governments globally to collaborate closely with public and private sector security experts and provide additional resources like guidance by the Cybersecurity and Infrastructure Security Agency (CISA) and other U.S. government agencies titled “Securing the Software Supply Chain”2 for software developers, suppliers and customers, to help ensure a more secure software supply chain. It is becoming imperative for organizations to consistently update their Software Development Life Cycle (SDLC), software and supply chain vulnerability, and risk management resources and practices. SBOM management aims to help mitigate potential vulnerabilities, maintain security and meet compliance requirements.

___________________________

1https://www.whitehouse.gov/briefing-room/presidential-actions/2021/05/12/executive-order-on-improving-the-nations-cybersecurity/ 

2https://www.cisa.gov/sites/default/files/publications/ESF_SECURING_THE_SOFTWARE_SUPPLY_CHAIN_DEVELOPERS.PDF. 2022 report by the Enduring Security Framework (ESF) Software Supply Chain Working Panel referencing NIST SP 800-218 and other secure software development and supply chain risk management guidance.
SBOM in Canadian Regulations – Bill C-26

Canada’s recent introduction of the C-26 legislation outlines the protection of critical cyber systems, laying the groundwork for improved software supply chain security, SBOM, and fostering a safer digital landscape. The Critical Cyber Systems Protection Act (CCSPA) aims to create a framework to protect critical cyber systems that support services vital to national security or public safety. The CCSPA seeks to ensure that risks to critical cyber systems are identified and managed, including risks associated with supply chains and the use of third-party products and services.3

This new Canadian legislation follows global trends, focusing on managing risks associated with supply chains and third-party products and services, ensuring that critical cyber systems remain protected from compromise and minimizing the impacts of cybersecurity incidents. Designated operators of these critical cyber systems will be required to establish and implement a cybersecurity program, mitigate supply-chain and third-party risks, and adhere to reporting and notification obligations in the event of a cybersecurity incident.

EU Cyber Resilience Act

Cybercrime costs reached $6 trillion in 2021, prompting the European Commission to propose the Cyber Resilience Act (CRA) to enhance software security. The CRA aims to hold manufacturers accountable for improving software security throughout the entire product life cycle and increase transparency into software vulnerabilities. A key strategy in the CRA is the implementation of Software Bill of Materials (SBOM) management, which tracks and shares metadata details of software components and supply chain relationships. Non-compliance with the CRA may lead to significant fines and reputational damage. As the CRA impacts software sold or used in Europe, adopting SBOM management now is crucial for future compliance and security.4

ai-in-genomics-market-to-reach-$98-billion,-globally,-by-2031-at-40.6%-cagr:-allied-market-research

AI In Genomics Market to Reach $9.8 Billion, Globally, by 2031 at 40.6% CAGR: Allied Market Research

April 13, 2023 Published by

 

Allied Market Research published a report, titled, “AI in Genomics Market by Offering (Hardware, Software, Services), by Technology (Machine Learning, Computer Vision), by Application (Drug Discovery and Development, Precision Medicine, Diagnostics, Others), by End User (Pharmaceutical and Biotech Companies, Healthcare Providers, Research Centers): Global Opportunity Analysis and Industry Forecast, 2021-2031″. According to the report, the global AI in genomics industry generated $346.3 million in 2021, and is anticipated to generate $9.8 billion by 2031, witnessing a CAGR of 40.6% from 2022 to 2031.

Download Free Sample Report: https://www.alliedmarketresearch.com/request-sample/11921

Prime determinants of growth

The rise in applications of AI in drug discovery and development coupled with the advancements in artificial intelligence technology drive the growth of the global AI in genomics market. However, limited availability of skilled professionals and data quality issues restrict the market growth.

Covid-19 Scenario

  • The outbreak of the Covid-19 pandemic had a negative impact on the global AI in genomics market, as it disrupted workflows in the healthcare sector around the world during the lockdown.
  • The disease had forced several industries to shut down temporarily, including several sub-domains of the healthcare sector. The pandemic reduced accessibility to the research centers and offices which delayed the development in AI programs.
  • However, AI-driven diagnostics emerged as great solution for quick diagnosis of the disease

The machine learning segment to maintain its leadership status throughout the forecast period

Based on technology, the mid-top sneakers segment held the highest market share in 2021, accounting for around three-fifths of the global AI in genomics market, and is estimated to maintain its leadership status throughout the forecast period. Moreover, the same segment is projected to manifest the highest CAGR of 40.9% from 2022 to 2031. This is due to the machine learning algorithms that can be used to integrate genomic data with other types of data, such as clinical and environmental data, to gain a more comprehensive understanding of the factors that contribute to disease risk and progression. In addition, machine learning algorithms can be used to predict the function of genes, identify regulatory elements, and annotate the genome.

The software segment to maintain its leadership status throughout the forecast period

Based on offering, the software segment held the highest market share in 2021, accounting for more than three-fifths of the global AI in genomics market, and is estimated to maintain its leadership status throughout the forecast period, owing to the increase in demand for precision medicine. However, the hardware segment is projected to manifest the highest CAGR of 41.0% from 2022 to 2031. AI hardware has been increasingly used in genomic analysis owing to the reason that AI enables the processing of vast amounts of data generated by genomic sequencing technologies.

Procure Complete Report (220 Pages PDF with Insights, Charts, Tables, and Figures) @ https://www.alliedmarketresearch.com/purchase-enquiry/11921

The pharmaceutical and biotech companies segment to maintain its lead position during the forecast period

Based on end user, the pharmaceutical and biotech companies segment accounted for the largest share in 2021, contributing to more than half of the global AI in genomics market, and is projected to maintain its lead position during the forecast period. AI genomics can help identify patients who are most likely to benefit from a particular drug by analyzing genomic data to identify biomarkers that are associated with the disease or condition being treated. This can help pharmaceutical and biotech companies design more targeted clinical trials, reducing the cost and time required to bring a drug to market. However, the healthcare providers segment is expected to portray the largest CAGR of 42.0% from 2022 to 2031, owing to the significant increase in use of AI for disease diagnosis in hospitals by healthcare providers.

North America to maintain its dominance by 2031

Based on region, North America held the highest market share in terms of revenue in 2021, accounting for nearly half of the global AI in genomics market, and is likely to dominate the market during the forecast period. This is attributed to a large number of universities and research institutions that are at the forefront of AI research, including Stanford, MIT, Carnegie Mellon University, and the University of California, Berkeley. These institutions attract top talent from around the world and conduct cutting-edge research. Furthermore, The U.S. government and private industry have invested heavily in AI research and development. However, the Asia-Pacific region is expected to witness the fastest CAGR of 46.9% from 2022 to 2031, owing to increase in investments for development of AI and an increase in the number of key players developing AI.

Leading Market Players: –

  • IBM Corporation,
  • Deep Genomics,
  • Thermo Fisher Scientific Inc.,
  • Illumina, Inc.,
  • Data4Cure, Inc,
  • BenevolentAI,
  • Microsoft Corporation,
  • NVIDIA Corporation (Mellanox Technologies),
  • Sophia Genetics,
  • Freenome Holdings, Inc

The report provides a detailed analysis of these key players of the global AI in genomics market. These players have adopted different strategies such as new product launches, collaborations, expansion, joint ventures, agreements, and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Magnetic Resonance Imaging (MRI) Coils Market by Type (Radiofrequency coil, Gradient coils), by Application (Body Oncology, Neuro and spine, Cardiovascular, Pediatric, Others), by End User (Hospitals and Clinics, Diagnostic Imaging Centers): Global Opportunity Analysis and Industry Forecast, 2021-2031

Skincare Market by Products (Creams and Moisturizers, Powder, Cleansers and Face Wash, Others), by Distribution Channel (Online, Offline), by Gender (Male, Female), by Packaging (Tubes, Bottles and Jars, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

C-Arms Market by Type (Mobile C-Arms, Fixed C-Arms), by Application (Cardiology, Gastroenterology, Neurology, Orthopedic and Trauma, Oncology, Others), by End User (Hospitals, Diagnostic Centers, Specialty Clinics): Global Opportunity Analysis and Industry Forecast, 2021-2031

Flow Diverters Market by Type (Pipeline embolization device, Silk flow diverter, Surpass flow diverter, Flow redirection endoluminal device, Others), by Application (Cerebral aneurysms, Multiple Intracranial Aneurysms, Others), by End User (Hospital and clinics, Ambulatory surgical center): Global Opportunity Analysis and Industry Forecast, 2021-2031

Behavioral Health Market by Disorder (Alcohol Use Disorders, Substance Abuse Disorders, Eating Disorders, ADHD, Others), by Service (Emergency Mental Health Services, Outpatient Counselling, Home-based Treatment Services, Inpatient Hospital Treatment Services, Other Services), by Age Group (Pediatric, Adult, Geriatric): Global Opportunity Analysis and Industry Forecast, 2021-2031

cheetah-mobile-announces-second-half-and-full-year-2022-unaudited-consolidated-financial-results

Cheetah Mobile Announces Second Half and Full Year 2022 Unaudited Consolidated Financial Results

April 13, 2023 Published by

 

Cheetah Mobile Inc. (NYSE: CMCM) (“Cheetah Mobile” or the “Company”), a China-based IT company, today announced its unaudited consolidated financial results for the second half and full year 2022 ended December 31, 2022.

Management Commentary

Mr. Sheng Fu, Cheetah Mobile’s Chairman and Chief Executive Officer, stated, ” While there are some challenges such as Covid-19 in 2022, we managed to increase our total revenue year over year by around 13% to RMB884.1 million (USD128.2 million) in 2022. Driven by elevated products, services and user experience, both the revenues from our membership business and number of subscribers have increased for more than ten quarters consecutively. Our global cloud service business and overseas advertising agency business also maintained good momentum and contributed to our revenue growth in 2022. Looking ahead, we remain confident in our long-term opportunities and growth. We will continue to pursue healthy and high-quality development in 2023. ”

Mr. Thomas Ren, Cheetah Mobile’s Chief Financial Officer, commented, “In 2022, we continued to take measures to control our expenses and improve our organizational efficiency. Our gross margin increased year over year from 67.2% to 71.4% in this year. We maintained a strong cash position of RMB1,672.7 million as of December 31, 2022. This gives us financial flexibility to execute the key strategic objectives we have set out for long-term growth. ”

Second Half 2022 Consolidated Financial Results

REVENUES

Total revenues were RMB527.0 million (US$76.4 million) in the second half of 2022, representing an increase of 40.7% year over year.

Revenues from the Company’s internet business increased by 41.6% year over year to RMB421.9 million (US$61.2 million) in the second half of 2022. The year-over-year increase was mainly due to our endeavors to increase user acquisition through multiple channels.

Revenues from the AI and others were RMB105.1 million (US$15.2 million) in the second half of 2022, representing a 37.5% year-over-year increase. The year-over-year increase was primarily attributable to the growth of our global cloud service business, overseas advertising agency business as well as the development of our E-coupon vending robot business.

COST OF REVENUES AND GROSS PROFIT

Cost of revenues decreased by 12.5% year over year to RMB129.3 million (US$18.8 million) in the second half of 2022. The year-over-year decrease was primarily attributable to decrease of advertising business related traffic acquisition costs and channel costs. Non-GAAP cost of revenues decreased by 12.4% year over year to RMB129.1 million (US$18.7 million) in the second half of 2022.

Gross profit increased by 75.4% year over year to RMB397.7 million (US$57.7 million) in the second half of 2022. Non-GAAP gross profit increased by 75.2% year over year to RMB398.0 million (US$57.7 million) in the second half of 2022.

Gross margin was 75.5% in the second half of 2022, compared to 60.5% in the second half of 2021. Non-GAAP gross margin was 75.5% in the second half of 2022, compared to 60.7% in the second half of 2021.

OPERATING INCOME/LOSS AND EXPENSES

Total operating expenses increased by 45.8% year over year to RMB497.2 million (US$72.1 million) in the second half of 2022. Total non-GAAP operating expenses increased by 47.3% year over year to RMB493.6 million (US$71.6 million) in the second half of 2022.

  • Research and development expenses decreased by 5.6% year over year to RMB85.9 million (US$12.5 million) in the second half of 2022. The year-over-year decrease was primarily due to the improvement of operational efficiency. Non-GAAP research and development expenses decreased by 3.8% year over year to RMB84.7 million (US$12.3 million) in the second half of 2022.
  • Selling and marketing expenses increased by 81.7% year over year to RMB306.5 million (US$44.4 million) in the second half of 2022. The year-over-year increase was from the marketing and promotion expenses related to our user acquisition. Non-GAAP selling and marketing expenses increased by 82.2% year over year to RMB305.7 million (US$44.3 million) in the first half of 2022.
  • General and administrative expenses increased by 21.5% year over year to RMB115.1 million (US$16.7 million) in the second half of 2022. The year-over-year increase was mainly from some one-time expenses. Non-GAAP general and administrative expenses increased by 22.5% year over year to RMB113.6 million (US$16.5 million) in the first half of 2022.

Operating loss was RMB99.5 million (US$14.4 million) in the second half of 2022, compared to RMB114.2 million in the same period of the last year. Non-GAAP operating loss was RMB95.6 million (US$13.9 million) in the second half of 2022, compared to RMB107.8 million in the same period of the last year.

Share-based compensation expenses were RMB3.9 million (US$0.6 million) in the second half of 2022, compared to RMB6.4 million in the same period of the last year.

OTHER EXPENSE, NET

Other expense, net was RMB351.6 million (US$51.0 million) in the second half of 2022, which was primarily from the impairment of some long-term investments.

NET INCOME/(LOSS) ATTRIBUTABLE TO CHEETAH MOBILE SHAREHOLDERS

Net loss attributable to Cheetah Mobile shareholders was RMB440.9 million (US$63.9 million) in the second half of 2022, compared to a net loss attributable to Cheetah Mobile shareholders of RMB428.5 million in the same period of the last year.

Non-GAAP net loss attributable to Cheetah Mobile shareholders was RMB437.0 million (US$63.4 million) in the second half of 2022, compared to a non-GAAP net loss attributable to Cheetah Mobile shareholders of RMB422.1 million in the same period of the last year.

NET INCOME/(LOSS) PER ADS

Diluted loss per ADS was RMB15.4 (US$2.2) in the second half of 2022, compared to diluted loss per ADS of RMB15.2 in the same period of the last year. Non-GAAP diluted loss per ADS was RMB15.3(US$2.2) in second half of 2022, compared to Non-GAAP diluted loss per ADS of RMB14.9 in the same period of the last year.

BALANCE SHEET

As of December 31, 2022, the Company had cash and cash equivalents, restricted cash and short-term investments of RMB1,672.7 million (US$242.5 million).

SHARES ISSUED AND OUTSTANDING

As of December 31, 2022, the Company had a total of 1,449,473,689 Class A and Class B ordinary shares issued and outstanding. On August 23, 2022, the Company announced that it changed the ratio of its American Depositary Share (“ADS”) to Class A ordinary share (“Share”) from one (1) ADS representing ten (10) Shares to one (1) ADS representing fifty (50) Shares, effective September 2, 2022. Accordingly, the Company has retrospectively revised the comparative data from the previous periods to conform to the requisite presentation for the current period.

Fiscal Year 2022 Consolidated Financial Results

REVENUES

Total revenues increased by 12.7% to RMB884.1 million (US$128.2 million) in 2022.

Revenues from the Company’s internet business increased by 6.7% year over year to RMB697.4 million (US$101.1 million) in 2022. The year-over-year increase was mainly due to the growth of our membership business.

Revenues from the AI and others increased by 42.7% year over year to RMB186.7 million (US$27.1 million) in 2022. The year-over-year increase was primarily attributable to growth of our global cloud service business, overseas advertising agency business as well as the development of our E-coupon vending robot and related business.

COST OF REVENUES AND GROSS PROFIT

Cost of revenues decreased by 2.0% year over year to RMB252.6 million (US$36.6 million) in 2022. The year-over-year decrease was primarily due to lower advertising business related traffic acquisition costs and channel costs. Non-GAAP cost of revenues decreased by 1.9% year over year to RMB251.9 million (US$36.5 million) in 2022.

Gross profit increased by 19.8% year over year to RMB631.5 million (US$91.6 million) in 2022. Non-GAAP gross profit increased by 19.7% year over year to RMB632.2 million (US$91.7 million) in 2022.

Gross margin was 71.4% in 2022, compared to 67.2% in 2021. Non-GAAP gross margin was 71.5% in 2022, compared to 67.3% in 2021.

OPERATING INCOME/LOSS AND EXPENSES

Total operating expenses increased by 13.3% year over year to RMB857.1 million (US$124.3 million) in 2022. Total non-GAAP operating expenses increased by 13.3% year over year to RMB849.9 million (US$123.2 million) in 2022.

  • Research and development expenses decreased by 14.5% year over year to RMB181.0 million (US$26.2 million) in 2022. The year-over-year decrease was due to improvement of operational efficiency. Non-GAAP research and development expenses decreased by 12.8% year over year to RMB179.4 million (US$26.0 million) in 2022.
  • Selling and marketing expenses increased by 28.8% year over year to RMB476.9 million (US$69.1 million) in 2022. This year-over-year increase was primarily due to the marketing and promotion expenses related to our user acquisition. Non-GAAP selling and marketing expenses increased by 28.7% year over year to RMB475.0 million (US$68.9 million) in 2022.
  • General and administrative expenses increased by 11.7% year over year to RMB214.3 million (US$31.1 million) in 2022. The year-over-year increase was mainly from some one-time expenses. Non-GAAP general and administrative expenses increased by 9.1% year over year to RMB210.6 million (US$30.5 million) in 2022.

Operating loss was RMB225.6 million (US$32.7 million) in 2022, compared to RMB229.6 million in 2021. Non-GAAP operating loss was RMB217.7 million (US$31.6 million) in 2022, compared to RMB222.4 million in 2021.

Share-based compensation expenses were RMB7.9 million (US$1.1 million) in 2022, compared to RMB7.2 million in 2021.

NET INCOME/(LOSS) ATTRIBUTABLE TO CHEETAH MOBILE SHAREHOLDERS

Net loss attributable to Cheetah Mobile shareholders was RMB513.5 million (US$74.4 million) in 2022, compared to a net loss attributable to Cheetah Mobile shareholders of RMB351.1 million in 2021.

Non-GAAP net loss attributable to Cheetah Mobile shareholders was RMB505.6 million (US$73.3 million) in 2022, compared to a non-GAAP net loss attributable to Cheetah Mobile shareholders of RMB344.0 million in 2021.

NET INCOME/(LOSS) PER ADS

Diluted loss per ADS was RMB18.1 (US$2.6) in 2022, compared to diluted  loss per ADS of RMB12.3 in 2021. Non-GAAP diluted loss per ADS was RMB17.8 (US$2.6) in 2022, compared to Non-GAAP diluted loss per ADS of RMB12.1 in 2021.

Business Outlook

For the first half of 2023, the Company expects its total revenues to be between RMB310 million (US$44.9 million) and RMB360 million (US$52.2 million). This amount reflects the Company’s current and preliminary expectations.

Exchange Rate

This press release contains translations of certain Renminbi amounts into U.S. dollars at specified rates solely for the convenience of readers. Unless otherwise noted, all translations from Renminbi to U.S. dollars in this press release were made at a rate of RMB6.8972 to US$1.00, the exchange rate in effect as of December 31, 2022, as set forth in the H.10 statistical release of the Federal Reserve Board. Such translations should not be construed as representations that RMB amounts could be converted into U.S. dollars at that rate or any other rate, or to be the amounts that would have been reported under accounting principles generally accepted in the United States of America (“U.S. GAAP”).

nixi-selects-genieatm-for-network-traffic-visibility

NIXI Selects GenieATM for Network Traffic Visibility

April 12, 2023 Published by

 

The National Internet Exchange of India (NIXI) recently announced its selection of GenieATM to manage its network infrastructure and ensure end-to-end network traffic visibility. This marks a new milestone for Genie Networks as it extends its market footprint across India and the SAARC region.

India is now arguably the most connected nation in the world. As a key contributor to the local internet ecosystem in the last 20 years, NIXI has been dedicated to lower the cost of internet access and improve the quality of internet experience. Tier-1 ISPs (Internet Service Providers) in the nation rely heavily on internet exchanges established by NIXI to reduce bandwidth costs and ensure service availability. A network infrastructure with the size and complexity like NIXI needs a scalable, carrier-grade solution to manage and optimize its network operations. With this in mind, NIXI turned to Genie Networks.

By deploying GenieATM for its backbone infrastructure, NIXI can now monitor its entire network traffic in real-time with a comprehensive view of its traffic status and traffic paths across its network infrastructure. With GenieATM, NIXI can quickly identify and resolve any potential issues, ensuring that its customers’ networks are always running at peak performance. Through GenieATM’s MSSP (Managed Security Service Provider) portal, NIXI can further extend the advantage of network visibility to its customers, meaning that they can now monitor their individual traffic with greater transparency and control over their network operations.

“We’re thrilled to be working with Genie Networks. GenieATM gives us the visibility and insights we need to achieve optimized network utilization and performance,” said Mr/s. [Name], [Job title] of NIXI. “And we look forward to delivering the same visibility to our customers as part of a better user experience.”

concrete-sealers-market-to-garner-$31-billion,-globally,-by-2031-at-6.4%-cagr,-says-allied-market-research

Concrete Sealers Market to Garner $3.1 Billion, Globally, By 2031 at 6.4% CAGR, Says Allied Market Research

April 12, 2023 Published by

 

Allied Market Research published a report, titled, “Concrete sealers Market by Type (Pertaining Sealers, Acrylics, Polyurethane, Epoxies, and Others), Application (Building and Construction, Industrial, Commercial, and Others), And Region (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2022-2031″. According to the report, the global concrete sealers industry generated $1.7 billion in 2021, and is estimated to reach $3.1 billion by 2031, witnessing a CAGR of 6.4% from 2022 to 2031.

Request PDF Brochure: https://www.alliedmarketresearch.com/request-sample/54174

Prime determinants of growth

The surge in demand for building and construction activity and emergence of DIY projects have enhanced the growth of the global concrete sealers market. In addition, strong economic growth has surged the establishments of industries where concrete sealers are used as a protective coating for washers, driers, steel pipes, fittings, structural inserts, and industrial equipment. This may propel the growth of the concrete sealers market. However, shortages of raw materials have led to an increase in the price of concrete sealers, which in turn, is expected to restrain the market growth. However, a rise in investment by the major key players is expected to create lucrative opportunities in the industry.


Report Coverage & Details:

Report Coverage

Details

Forecast Period

2022–2031

Base Year

2021

Market Size in 2021

$3.1 billion

Market Size in 2031

$1.7 billion

CAGR

6.4 %

No. of Pages in Report

426

Segments covered

Type, Application, and Region.

Drivers

Escalating demand from building and construction sector 

Robust demand from automotive and transportation sector

Expansion of industrial development

Opportunities

Emergence of DIY projects

Growing demand for concrete sealers in the commercial sectors

Restraints

Volatility in prices of concrete sealers and other restraining factor associated with it

Side effect of using concrete sealers 

Covid-19 Scenario

  • Volatility in prices of raw materials lowered the market demand, thus impacting the growth of the concrete sealers industry negatively during the pandemic.
  • However, the rise in demand from the building and construction, industrial, automotive, and commercial sectors and increasing focus on an escalating economic recovery across the globe has supported the concrete sealers market growth in 2021.

The pertaining sealers segment to maintain its leadership status throughout the forecast period

Based on type, the pertaining sealers segment held the highest market share in 2021, accounting for more than one-third of the global concrete sealers market revenue and is estimated to maintain its leadership status throughout the forecast period. Sustained economic growth has surged the need for a faster and more reliable mode of transportation where pertaining concrete sealers are widely used as a protective coating on driveways. This may act as one of the key drivers responsible for the growth of the concrete sealers market. Furthermore, factors such as increase in disposable income, technological upgrades, and a spurring rise in number of original equipment manufacturers (OEMs) have led the automotive & transportation sector to witness significant growth where pertaining concrete sealers are used as a coating for corrosion resistance purposes. However, the acrylics segment is projected to manifest the highest CAGR of 7.0% from 2022 to 2031.

Procure Complete Report (426 Pages PDF with Insights, Charts, Tables, and Figures) @ https://bit.ly/3UBmIzy

The commercial application segment to maintain its lead position during the forecast period

Based on application, the commercial segment accounted for the largest share in 2021, contributing to nearly two-fifth of the global concrete sealers market revenue, and is estimated to maintain its leadership status throughout the forecast period.  The same segment is projected to manifest the highest CAGR of 6.7% from 2022 to 2031. The expansion of the commercial industry and increase in working population and government schemes and high potential investment in developing commercial building across the globe has driven the concrete sealers market.

Asia-Pacific to maintain its dominance by 2031

Based on region, Asia-Pacific held the highest market share in terms of revenue in 2021, accounting for more than two-fifths of the global concrete sealers market revenue and is estimated to maintain its leadership status throughout the forecast period.  Moreover, the same region is expected to witness the fastest CAGR of 7.1% from 2022 to 2031, owing to the rise in building & construction, transportation, chemical manufacturing, and other sectors have enhanced the performance of the concrete sealers in the Asia-Pacific region.

Leading Market Players: –

  • BASF SE,
  • Sika AG,
  • PPG Industries,
  • Laticrete International, Inc.,
  • Royal Associates,
  • Valspar,
  • Prosoco Corporation,
  • Mapei Corporation,
  • W. R. Meadows, Inc.,
  • XETEX INDUSTRIES PRIVATE LIMITED INDIA

The report provides a detailed analysis of these key players of the global concrete sealers market. These players have adopted different strategies such as new product launches, collaborations, expansion, joint ventures, agreements, and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.

Want to Access the Statistical Data and Graphs, Key Players’ Strategies:
https://www.alliedmarketresearch.com/concrete-sealers-market/purchase-options

Similar Reports:

Concrete Admixtures Construction Chemical Market: Global Opportunity Analysis and Industry Forecast, 2015-2023

Concrete Fiber Market: Global Opportunity Analysis and Industry Forecast, 2021-2031

Insulated Concrete Form (ICF) Market: Global Opportunity Analysis and Industry Forecast, 2021-2030

Polished Concrete Market: Global Opportunity Analysis and Industry Forecast, 2021-2031

Construction Chemicals Market: Global Opportunity Analysis and Industry Forecast, 2019 – 2026

Concrete Conditioner Market: Global Opportunity Analysis and Industry Forecast, 2021-2030

plasma-protein-therapeutics-market-to-reach-$44,29678-million,-globally,-by-2031-at-5.2%-cagr:-allied-market-research

Plasma Protein Therapeutics Market to Reach $44,296.78 million, Globally, by 2031 at 5.2% CAGR: Allied Market Research

April 12, 2023 Published by

 

Allied Market Research published a report, titled, “Plasma Protein Therapeutics Market by product type (Immunoglobulin, Albumins, Plasma Derived Factor VIII and Others), by Application (Hemophilia, Idiopathic Thrombocytopenic purpura, Primary Immunodeficiency Disorder and Others) by End User (Hospital and Others): Global Opportunity Analysis and Industry Forecast, 2022-2031″. According to the report, the global plasma protein therapeutics generated $26,527.82 million in 2021, and is anticipated to generate $44,296.78 million by 2031, witnessing a CAGR of 5.2% from 2022 to 2031.

Download Free Sample Report: https://www.alliedmarketresearch.com/request-sample/13057

Prime determinants of growth

Rise in adoption of key strategies by key players, increase in number of product approvals and product launch and further rise in demand of advanced therapeutics owing to rise in autoimmune disorders and other chronic diseases and surge in demand of effective treatment solutions drive the growth of the global plasma protein therapeutics market. However, strict regulations for handling plasma protein products are expected to restrict the growth of the plasma protein therapeutics market. On the contrary, the growing technological advancement are expected to offer remunerative opportunities for expansion of the plasma protein therapeutics market during the forecast period.

Report coverage & details:

Report Coverage

Details

Forecast Period

2022–2031

Base Year

2021

Market Size in 2021

$26,527.82 million

Market Size in 2031

$44,296.78 million

CAGR

5.2 %

No. of Pages in Report

389

Segments covered

Product type, Application, End User and Region.

Drivers

Rise in demand for advanced therapeutics

Rise in adoption of strategies by key market players

Increase in product approval and product development

Opportunities

Technological advancements

Restraints

Strict regulation for handling plasma protein products

Covid-19 Scenario

  • Due to the COVID-19 pandemic and the subsequent global lockdowns, the plasma protein therapeutics market faced a downturn.
  • However, after the pandemic restrictions are lifted, it is expected that the supply of plasma will increase, leading to an increase in the production and availability of plasma-derived therapies.

The immunoglobulin segment to maintain its leadership status throughout the forecast period

Based on product type, the immunoglobulin segment held the highest market share in 2021, accounting for more than half of the global plasma protein therapeutics market revenue, and is and is projected to manifest the highest CAGR of 5.6% during forecast period, owing to increase in availability of innovative immunoglobulin products and developments in therapeutic administration, such as the subcutaneous immunoglobulin products.

The hemophilia segment to maintain its leadership status throughout the forecast period

Based on application, the Hemophilia segment held the highest market share in 2021, accounting for nearly three-fifthof the global plasma protein therapeutics market revenue, and is estimated to maintain its leadership status throughout the forecast period, owing to the rise in people diagnosed with hemophilia and increase in availability of plasma protein therapeutics options for hemophilia. However, the primary immunodeficiency disorder segment is projected to manifest the highest CAGR of 5.8% from 2022 to 2031, owing to rise in awareness regarding use of plasma protein therapeutics for the treatment of the primary immunodeficiency and their high prevalence.

Procure Complete Report (220 Pages PDF with Insights, Charts, Tables, and Figures) @ https://www.alliedmarketresearch.com/checkout-final/plasma-protein-therapeutics-market

The hospital segment to maintain its lead position during the forecast period

Based on end user, the hospital segment accounted for the largest share in 2021, contributing around three-fourth of the global plasma protein therapeutics market revenue, owing to increase in number of patient visits in hospitals suffering from autoimmune conditions such as hemophilia and ease of access of protein therapeutics in hospital. However, the others segment is expected to portray the largest CAGR of 5.6% from 2022 to 2031, and is projected to maintain its lead position during the forecast period. This is owing to cost effectiveness, and ease of scheduling visits.

North America to maintain its dominance by 2031

Based on region, North America held the highest market share in terms of revenue in 2021, accounting for nearly half of the global plasma protein therapeutics market revenue, owing to rise in investments for plasma protein therapeutics research, increase in cases of rare diseases and high prevalence of immunological disorders. However, the Asia-Pacific region is expected to witness the fastest CAGR of 6.0% from 2022 to 2031, and is likely to dominate the market during the forecast period, owing to enhancements in healthcare facilities and improvements in patient awareness about plasma protein therapeutics.

Leading Market Players: –

  • Octapharma Ag
  • Grifols, S.A.
  • Baxter International Inc.
  • Adma Biologics Inc
  • Bio Products Laboratory Ltd
  • Takeda Pharmaceutical Company Limited
  • CSL Limited
  • Kedrion, Spa
  • Taibang Biological Group Co., Ltd
  • Bayer AG

The report provides a detailed analysis of these key players of the global plasma protein therapeutics market. These players have adopted different strategies such as new product launches, acquisition, agreements, product approval and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Endoscopic Ultrasound (EUS) Market by Product (Endoscopes, Ultrasound probes, Ultrasonic processors, Imaging system, Needles, Accessories), by Application (Oncology, Pancreatic conditions, Others), by End user (Hospitals, Ambulatory surgery centers and Clinics, others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Skin Cancer Treatment Market by Type (Melanoma, Non-Melanoma), by Therapy (Immunotherapy, Targeted Therapy, Chemotherapy), by Distribution Channel (Hospitals Pharmacies, Drug Stores and Retail Pharmacies, Online Providers): Global Opportunity Analysis and Industry Forecast, 2021-2031

Behavioral Health Market by Disorder (Alcohol Use Disorders, Substance Abuse Disorders, Eating Disorders, ADHD, Others), by Service (Emergency Mental Health Services, Outpatient Counselling, Home-based Treatment Services, Inpatient Hospital Treatment Services, Other Services), by Age Group (Pediatric, Adult, Geriatric): Global Opportunity Analysis and Industry Forecast, 2021-2031

Laser Hair Removal Market by Type (Alexandrite laser hair removal, Diode laser hair removal, Others), by Gender (Male, Female), by Age group (13 to 29, 30 to 54, 55 to 69), by End User (Hospitals, Clinic, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Bone Void Fillers Market by Type (Demineralized bone matrix, Calcium phosphate bone graft substitute, Collagen Matrix, Others), by Form (Gel and Putty, Granules, Others), by Application (Spine fusion, Bone fracture, Others), by End User (Hospital, Specialty Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

eskute-rolls-out-product-upgrades-for-2023

ESKUTE Rolls Out Product Upgrades for 2023

April 12, 2023 Published by

 

ESKUTE, a fast-growing e-bike company, is rolling out a series of product upgrades to its product range in response to positive demand for its two-wheelers from the market.

As the company expanded, ESKUTE’s product sales grew rapidly in 2022. The company has listened fully to customers’ needs and aims to provide a better riding experience for them this year. Among the highlights of the upgrades is the new series of Torque sensors, equipped with ESKUTE’s self-developed intelligence Pedal Assist System (IntelligentPas), meaning riders can better save battery life and use their two-wheelers for longer.

The market response to ESKUTE’s products was positive across the board. Enrico Punsalang, a motorcycle enthusiast and writer at RideApart and InsideEVs commented, “I already have a Netuno and Netuno pro, and they give me a different riding experience. The Netuno pro’s torque sensor makes the pedal assist feel much more natural and intuitive, and they’re a pretty awesome piece of kit to have on electric bikes. If you actually like to pedal your e-bike (as opposed to just using the throttle), then a torque sensor is a better choice. ”

As part of the new improvements for this year, the Netuno and Polluno have been upgraded to Plus models through the use of the IntelligencePas technology. The polluno battery has also been improved from 36V 14.5AH cells to 36V 20AH, providing users with a 30% increase in range and also extending the service life of the whole bike by 30%. The motor has also been improved, going from the previous BAFANG G010 250W to a BAGANG G020 250W, thereby raising the torque. This means users don’t have to work as hard to get their pedals moving on their two-wheeler. ESKUTE has also added a 26-inch version for those with a smaller frame and added a new white-color version to give more riding options for users.

Besides the upgrades, ESKUTE is also launching a brand-new e-bike model this year, the Star, which is a folding fat-tire electric bike. The new model is portable and storable while also powerful, comfortable, and ready for anything that users throw at it. This compact two-wheeler can easily fit inside riders’ closets at home or under their desks in the office, thereby adding to its almost infinite portability! Equipped with 4″ fat tires and a front suspension fork, users will be all set to cruise the pavements and conquer the trails on this e-bike!

Looking beyond ESKUTE’s upgrades for its products and new models this year, ESKUTE is also taking aim at improving its customer service offering. This drive includes building a global customer service system comprised of local customer call centers in Germany, the UK, and the US to ensure user inquiries receive immediate responses. This move is part of ESKUTE’s efforts to triple its turnover compared with last year and provide more and more green mobility solutions to people all around the world.

ceramic-tiles-market-worth-$320.5-billion-by-2027-–-exclusive-report-by-marketsandmarkets

Ceramic Tiles Market worth $320.5 billion by 2027 – Exclusive Report by MarketsandMarkets™

April 12, 2023 Published by

 

The report “Ceramic Tiles Market by Type (Porcelain, Glazed, Unglazed), Application (Floor Tiles, Internal Wall Tiles, External Wall Tiles) End-use Sector (Residential, Non-residential), Finish (Matt, Gloss), Construction Type, and Region – Global Forecast to 2027″, is approximated to be USD 227.9 billion in 2022, and it is projected to reach USD 320.5  billion by 2027, at a CAGR of 7.1%.

The Ceramic tiles market is experiencing significant growth driven by several factors, including the increasing population & urbanization, growing investments in construction industry, increasing industrialization, and rising number of renovation activities. However, the volatile raw material prices may limit market growth. Despite these challenges, opportunities exist in the market for rapidly progressing organized retail sector. The Ceramic tiles industry also faces the challenge of extreme competition in the market.

Browse in-depth TOC on “Ceramic Tiles Market”

218 – Tables
49 – Figures
208 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=228236779

By type, Glazed Tiles accounted for the 2nd largest share in 2021

Ceramic tiles on which a liquefied layer of glass is added are called glazed tiles. When a tile is being glazed, it is coated by liquid, which is colored glass. It is sprayed or poured on to cover it. The glaze is then baked onto the surface by placing it in a kiln at a temperature of more than 1,000°C. A second firing is given to the tile in the kiln, depending on the type. The glaze can give the tile a smooth or textured surface and offers an infinite variety of colors and designs. Glazed tiles typically have a matte, semi-gloss, and high gloss finish. They provide better stain and moisture resistance than unglazed tiles. Owing to the extra liquefied glass layer, custom tile designs can be added to them. This allows the floor tile designs to be available in multiple colors. Owing to their vibrant allure, these are mostly used for kitchen floors and bathroom walls.

By Application, Internal Wall Tiles accounted for the 2nd largest share in 2021.

Ceramic wall tiles are being used in an increasing number of settings, such as homes, offices, hospitals, and laboratories. These also help in significantly altering the appearance and atmosphere of any room. Wall tile is typically more delicate, smoother, and thinner. In addition, wet surfaces are significantly slicker, which is why wall tile should not be used as a flooring material. There are several benefits to using this versatile product. Ceramic tiles are great choices for kitchen and shower walls, as they are comparatively easier to maintain and clean than paint or wallpaper. Furthermore, ceramic wall tiles are also highly resilient to abrasive chemicals and cleaners, which makes them easy to keep clean. Ceramic wall tiles are also widely used in bathrooms; as they are resistant to humidity and moisture, which is ideal for damp environments found in bathrooms. Other characteristics of ceramic tiles which enable their application on the walls include stain resistance, fire resistance, high durability, fade resistance, and odor resistance.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=228236779

By End-Use Sector, Non-residential Segment accounted for the 2nd largest share in 2021.

The non-residential buildings can be classified into commercial, institutional & healthcare, and public facilities. In this sector, the demand for ceramic tiles is expected to be driven by increasing spending on office spaces and other commercial & institutional constructions where ceramic tiles are used extensively. Floors of non-residential buildings need to withstand heavy foot traffic and heavy furniture load. The application of ceramic tiles in non-residential structures adds to the aesthetic value of the interior space.

Europe accounted for the second largest share of the Ceramic tiles Market in 2021

The expansion of the European construction market can be attributed to the rising demand for housing in urban areas, increased infrastructure development activities, and increased modernization and renovation of buildings to improve their energy efficiency. With the region’s robust economic growth, commercial infrastructure construction, such as offices, schools, hotels, restaurants, and leisure facilities, is on the rise. Furthermore, the introduction of various favorable initiatives and investments by governments to improve housing infrastructure and provide housing for the vulnerable section is supporting the growth of the European construction market.

The Ceramic tiles Market comprises major players such as SCG Ceramics (Thailand), RAK Ceramics (UAE), Grupo Lamosa (Mexico), Mohawk Industries Inc. (US), and Kajaria Ceramics (India) and others are covered in the Ceramic tiles market. Expansions, acquisitions, joint ventures, and new product developments are some of the major strategies adopted by these key players to enhance their positions in the Ceramic tiles Market.

Browse Adjacent Market: Ceramics and Glass Market Research & Consulting

Related Reports:

Flooring Market – Global Forecast to 2023

Carpets & Rugs Market– Global Forecast to 2022

svkm’s-mastermind-career-fair-2023:-one-stop-destination-for-a-successful-career

SVKM’s Mastermind Career Fair 2023: One-stop Destination for a Successful Career

April 11, 2023 Published by

 

Shri Vile Parle Kelavani Mandal is launching Mastermind, an initiative to help students choose the right career path. As one of the country’s top educational trust, SVKM has brought together experts from prestigious institutions like SVKM’s NMIMS Deemed-to-be University, Mithibai College of Arts and Chauhan Institute of Sciences, Narsee Monjee College of Commerce and Economics, Jitendra Chauhan College of Law, Dwarkadas J. Sanghvi College of Engineering, Dr. Bhanuben Nanavati College of Pharmacy, Shri Bhagubhai Mafatlal Polytechnic, and more for the career fair.

Mastermind is designed mainly to provide students of Std. XI and XII with detailed information about the various undergraduate programs offered by SVKM. The event will cover a wide range of streams, including Engineering, Sciences, Pharmacy, Interior-Environment & Design, Architecture, Commerce, Management, Branding & Advertising, Economics, Liberal Arts, Music, Hospitality, Law, and Design (Humanising Technology). The fair also caters to students who have desires of pursuing Post Graduate or Higher studies.

The event will be held on 16th April 2023 at B. J. Hall, V. L. Mehta Road, Vile Parle (West) from 9:00 AM to 5:00 PM. Students and parents are welcome to walk in and benefit from the expertise of the subject matter experts present.

SVKM’s career fair offers a comprehensive experience for students and parents to learn about all the programs offered by the Institutions of SVKM which includes NMIMS University. Participants can interact with subject matter experts to discuss and shape their future. Students can gather detailed information about various streams including Engineering & Technology Management, Artificial intelligence, Machine Learning, Data Science, Information technology, Computer Science, Electronics and Telecommunication Engineering, Mechanical Engineering, Mechatronics, Civil Engineering, Pharmacy, Architecture, Commerce, Economics, Law, Science, Liberal Arts, Design (Humanising Technology), Performing Arts, Mathematical Science, Agricultural Science, Hospitality Management, Branding, Advertising and more.

Latest Members

Recent AchievementsYou must be logged in to view earned achievements

What is a Wire Coin?

Find connections

Who is online

Latest Hashtags

#artificialintelligence #betting #blockchain #casino #esports #fintech #gaming #hiptherfestival #hipthers #igaming #slots #technology